Supplement - Discovering the role of YES1 in triple negative breast cancer

$365,768R01FY2024CANIH

Cleveland Clinic Lerner Com-Cwru, Cleveland OH

Investigators

Ruth A Kericontact

Linked publications, trials & patents

Paper 39037997 Paper 38627584 Paper 37878345 Paper 37720048 Paper 37394919 Paper 37292816 Paper 34606589

View original record on NIH RePORTER →

Supplement - Discovering the role of YES1 in triple negative breast cancer · GrantIndex